Bill & Melinda Gates Foundation Strategic Investment Fund

Bill & Melinda Gates Foundation Strategic Investment Fund

The Strategic Investment Fund (SIF) is a for-profit investment arm of the Bill & Melinda Gates Foundation.

Portfolio

Companies in the SIF portfolio include:[1][2][3]

  • Abbott Laboratories
  • Abraaj Growth Markets Health Fund
  • Achaogen
  • Acrobatiq
  • Adjuvant Capital
  • Affinivax
  • Africa Health Fund
  • African Agricultural Capital Fund
  • African Leadership Foundation
  • AgBiome
  • AgTech Accelerator
  • Amyris
  • Anacor Pharmaceuticals
  • Arsanis
  • Aspire Public Schools
  • Atreca
  • Aurobindo Pharma
  • Avanti Finance
  • Bayer
  • Beijing Bio-Institute Biological Products (BBIBP)
  • Biological E. Limited
  • BioFarma
  • BioNTech
  • bKash
  • BloomBoard
  • Butterfly Network
  • Charter School Growth Fund (CSGF)
  • Civic Builders
  • Clinton Health Access Initiative (CHAI)
  • ClinVet
  • CropIn
  • CureVac
  • DKT International
  • Dr. Reddy's Laboratories
  • Eastside Preparatory School
  • Eli Lilly
  • Enko Chem
  • Evolve BioSystems
  • Exscienta
  • Gavi, the Vaccine Alliance
  • Genocea Biosciences
  • Global Health Investment Fund (GHIF)
  • Halodoc
  • Hester Biosciences
  • Immunocore
  • Intarcia
  • Inventprise
  • Just Biotherapeutics
  • KIPP Texas
  • Kymab
  • Liquidia
  • Lodo Therapeutics
  • LumiraDx
  • Lyndra Therapeutics
  • M-KOPA
  • Medical Credit Fund (MCF)
  • Merck
  • Mylan
  • Novartis
  • OneLoad
  • OraSure Technologies
  • Owl Ventures
  • Pan American Health Organization (PAHO)
  • Pfizer[4]
  • Pledge Guarantee for Health (PGH)
  • Provivi
  • Reach Capital
  • Root Capital
  • Sanofi
  • SD Biosensor
  • Sera Prognostics
  • Serum Institute of India (SII)
  • Stellapps
  • SwipeRx
  • Synlogic
  • Tata 1mg
  • UNICEF
  • United Nations Population Fund (UNFPA)
  • Ustar Biotechnologies
  • Uversity
  • Vaccine Independence Initiative (VII)
  • Vedanta Biosciences
  • Vir Biotechnology
  • Visterra
  • World Health Organization (WHO)
  • Zyomyx

  1. Portfolio - Page 1. Bill & Melinda Gates Foundation Strategic Innovation Fund. Retrieved December 24, 2023, from https://web.archive.org/web/20231224051809/https://sif.gatesfoundation.org/portfolio/?fwp_per_page=30 ↩︎

  2. Portfolio - Page 2. Bill & Melinda Gates Foundation Strategic Innovation Fund. Retrieved September 27, 2023, from https://web.archive.org/web/20230927091305/https://sif.gatesfoundation.org/portfolio/?fwp_paged=2&fwp_per_page=30 ↩︎

  3. Portfolio - Part 3. Bill & Melinda Gates Strategic Innovation Fund. Retrieved December 24, 2023, from https://web.archive.org/web/20231224080252/https://sif.gatesfoundation.org/portfolio/?fwp_paged=3&fwp_per_page=30 ↩︎

  4. Pfizer. Gates SIF. Retrieved June 22, 2021, from http://archive.today/2021.06.22-183302/https://sif.gatesfoundation.org/investments/pfizer/ ↩︎

About the author
Liam Sturgess

Liam Sturgess

Liam Sturgess is a Canadian writer, researcher and investigative reporter focused on issues of human rights and civil liberties, with a particular interest in the COVID-19 pandemic. He is the founder of White Rose Intelligence.

Knowledge is Freedom

Research and intelligence in defense of liberty

White Rose Intelligence

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to White Rose Intelligence.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.